chr8-22713405-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144962.3(PEBP4):āc.649A>Cā(p.Lys217Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000412 in 1,455,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEBP4 | NM_144962.3 | c.649A>C | p.Lys217Gln | missense_variant | 7/7 | ENST00000256404.8 | NP_659399.2 | |
PEBP4 | NM_001363233.2 | c.649A>C | p.Lys217Gln | missense_variant | 7/7 | NP_001350162.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEBP4 | ENST00000256404.8 | c.649A>C | p.Lys217Gln | missense_variant | 7/7 | 1 | NM_144962.3 | ENSP00000256404.6 | ||
ENSG00000253125 | ENST00000523627.1 | n.164+23092T>G | intron_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1455744Hom.: 0 Cov.: 36 AF XY: 0.00000414 AC XY: 3AN XY: 724190
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.649A>C (p.K217Q) alteration is located in exon 7 (coding exon 6) of the PEBP4 gene. This alteration results from a A to C substitution at nucleotide position 649, causing the lysine (K) at amino acid position 217 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at